サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1533902

新生児聴覚スクリーニング装置の世界市場

Neonatal Hearing Screening Devices

出版日
ページ情報
英文 274 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.64円
新生児聴覚スクリーニング装置の世界市場
出版日: 2024年08月14日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 274 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

新生児聴覚スクリーニング装置の世界市場は2030年までに4,940万米ドルに達する見込み

2023年に3,960万米ドルと推定される新生児聴覚スクリーニング装置の世界市場は、2030年には4,940万米ドルに達し、分析期間2023-2030年のCAGRは3.2%で成長すると予測されます。本レポートで分析したセグメントの1つである聴性脳幹反応（ABR）システムは、CAGR 3.3％を記録し、分析期間終了までに2,250万米ドルに達すると予測されます。Otoacoustic Emission（OAE）システム分野の成長率は、分析期間中CAGR 3.8％と推定されます。

米国市場は1,080万米ドル、中国はCAGR6.2％で成長予測

米国の新生児聴覚スクリーニング装置市場は2023年に1,080万米ドルと推定されます。世界第2位の経済大国である中国は、2023年から2030年の分析期間においてCAGR 6.2%で推移し、2030年には予測市場規模1,010万米ドルに達すると予測されています。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ1.0％と2.4％と予測されています。欧州では、ドイツがCAGR 1.7%で成長すると予測されています。

世界の新生児聴覚スクリーニング装置市場- 主要動向と促進要因まとめ

新生児聴覚スクリーニングは、子どもの言語能力、社会性の発達に大きな影響を与える難聴を特定するための重要な早期介入手段として認識されています。新生児聴覚スクリーニング（UNHS）は、聴覚障害を早期に発見することで、その影響を大幅に軽減できる可能性があるため、世界中の病院で導入が進んでいます。新生児聴覚スクリーニングは、生後間もなく実施され、一連の非侵襲的で痛みを伴わない検査によって、赤ちゃんの聴覚の健康状態を迅速に判定することができます。赤ちゃんの言語発達能力は生後1年で加速度的に向上するため、将来のコミュニケーションや教育上の課題を予防するためには、早期発見と介入が不可欠です。

技術の進歩により、新生児聴覚スクリーニングの有効性と利用しやすさが大幅に向上しました。最新の機器では、音響放射（OAE）と聴性脳幹反応（ABR）の両方の検査が統合されており、CE-Chirpのような改良された刺激により、より迅速で正確な総合的な聴覚評価が可能になっています。この統合により、スクリーニング・プロセスが簡素化され、複数の機器の必要性が減少し、全体的な検査時間が短縮されます。さらに、これらの機器の進化により、より使いやすくなり、データベースへの接続が可能になったため、患者の記録を体系的に管理・分析することができ、フォローアップケアや聴覚の健康に関する縦断的研究が容易になった。

新生児聴覚スクリーニング市場の成長は、十分なサービスを受けていない地域へのリーチを拡大する遠隔医療サービスとの機器の統合などの技術的進歩を含むいくつかの要因によって牽引されています。さらに、センサー技術の強化はスクリーニングの精度と信頼性を向上させ、その採用を増加させています。ポータブルで使いやすいデザインの機器は、病院だけでなくコミュニティセンターや家庭での使用も促進し、早期発見の範囲を広げています。さらに、教育キャンペーンや規制当局の支援に裏打ちされた消費者の意識の向上が、より広く日常的な使用を促しています。機器メーカーとヘルスケア専門家の協力により、機器の改良が続けられ、臨床環境への適応性と有効性が高まっています。これらのスクリーニング・プロトコルを採用する病院に対する経済的インセンティブは、より広範な導入を保証し、この必要不可欠なヘルスケア技術の全体的な成長と発展に貢献しています。

調査対象企業の例（全37件）

  • Draeger India Private Limited
  • Echodia S.A.S
  • Grason-Stadler, Inc.
  • Guangzhou Melison Medical Instrument Co., Ltd.
  • iClear Healthcare
  • Intelligent Hearing Systems Corp.
  • Interacoustics A/S
  • MAICO Diagnostics GmbH
  • Natus Medical Incorporated
  • Neurosoft
  • Otodynamics Ltd
  • Path Medical GmbH
  • Pilot Blankenfelde medizinisch elektronische Gerate GmbH
  • Sohum Innovation Lab
  • Vivosonic Inc.;

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • スペイン
  • ロシア
  • その他欧州
  • アジア太平洋
  • オーストラリア
  • インド
  • 韓国
  • その他アジア太平洋地域
  • ラテンアメリカ
  • アルゼンチン
  • ブラジル
  • メキシコ
  • その他ラテンアメリカ
  • 中東
  • イラン
  • イスラエル
  • サウジアラビア
  • アラブ首長国連邦
  • その他中東
  • アフリカ

第4章 競合

目次
Product Code: MCP24719

Global Neonatal Hearing Screening Devices Market to Reach US$49.4 Million by 2030

The global market for Neonatal Hearing Screening Devices estimated at US$39.6 Million in the year 2023, is expected to reach US$49.4 Million by 2030, growing at a CAGR of 3.2% over the analysis period 2023-2030. Auditory Brainstem Response (ABR) Systems, one of the segments analyzed in the report, is expected to record a 3.3% CAGR and reach US$22.5 Million by the end of the analysis period. Growth in the Otoacoustic Emission (OAE) Systems segment is estimated at 3.8% CAGR over the analysis period.

The U.S. Market is Estimated at US$10.8 Million While China is Forecast to Grow at 6.2% CAGR

The Neonatal Hearing Screening Devices market in the U.S. is estimated at US$10.8 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$10.1 Million by the year 2030 trailing a CAGR of 6.2% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.0% and 2.4% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 1.7% CAGR.

Global Neonatal Hearing Screening Devices Market - Key Trends and Drivers Summarized

Neonatal hearing screening is recognized as a crucial early intervention measure to identify hearing loss, which can profoundly impact a child's development of speech, language, and social skills. Hospitals around the world are increasingly incorporating Universal Newborn Hearing Screening (UNHS) programs, motivated by the potential to significantly mitigate the effects of auditory impairments recognized early in life. The process, conducted shortly after birth, involves a series of non-invasive, painless tests that can quickly determine a baby's auditory health status. This proactive approach is crucial because a baby’s capacity for speech and language development accelerates within the first year of life, making early detection and intervention essential for preventing future communicative and educational challenges.

Technology advancements have greatly enhanced the efficacy and accessibility of newborn hearing screenings. Modern devices integrate both Otoacoustic Emissions (OAE) and Auditory Brainstem Response (ABR) tests, allowing for comprehensive auditory assessments that are both faster and more accurate, thanks to improved stimuli like CE-Chirp. This integration simplifies the screening process, reduces the need for multiple devices, and accelerates the overall testing time—factors that increase efficiency in a clinical setting. Moreover, the evolution of these devices has made them more user-friendly and capable of connecting to databases, which helps in maintaining and analyzing patient records systematically, facilitating follow-up care and longitudinal studies on auditory health.

The growth in the neonatal hearing screening market is driven by several factors including technological advancements, such as the integration of devices with telehealth services, which expand reach to underserved areas. Additionally, enhancements in sensor technology improve the accuracy and reliability of screenings, increasing their adoption. Portable and user-friendly designs of the devices promote their use not only in hospitals but also in community centers and at home, broadening the scope of early detection. Furthermore, increased consumer awareness, backed by educational campaigns and regulatory support, encourages more widespread and routine use. Collaboration between device manufacturers and healthcare professionals continues to refine the devices, making them more adaptable and effective in clinical environments. Economic incentives for hospitals to adopt these screening protocols ensure a broader implementation, contributing to the overall growth and development of this essential healthcare technology.

Select Competitors (Total 37 Featured) -

  • Draeger India Private Limited
  • Echodia S.A.S
  • Grason-Stadler, Inc.
  • Guangzhou Melison Medical Instrument Co., Ltd.
  • iClear Healthcare
  • Intelligent Hearing Systems Corp.
  • Interacoustics A/S
  • MAICO Diagnostics GmbH
  • Natus Medical Incorporated
  • Neurosoft
  • Otodynamics Ltd
  • Path Medical GmbH
  • Pilot Blankenfelde medizinisch elektronische Gerate GmbH
  • Sohum Innovation Lab
  • Vivosonic Inc.;

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Global Economic Update
    • Neonatal Hearing Screening Devices - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Need to Identify Congenital Deafness & Hearing Impairment in Newborns Drives Demand
    • Technological Advancements in Screening Devices Enhance Detection Accuracy
    • Smartphone-Based Hearing Test for Infants Ignites Interest in the Market
    • Growing Healthcare Expenditure in Emerging Markets Bolsters Device Adoption
    • Development of Low-cost Earbuds Makes Newborn Hearing Screening Accessible
    • Telemedicine for Audiology Screening of Infants Rises in Popularity
    • Economic Burden of Undiagnosed Hearing Loss Supports Case for Early Screening
    • Adoption of Newborn Hearing Screening in Private Healthcare Sectors
    • Growing Number of Births in Medical Facilities Increases Market Coverage
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Neonatal Hearing Screening Devices Market Analysis of Annual Sales in US$ for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Neonatal Hearing Screening Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Neonatal Hearing Screening Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 4: World 16-Year Perspective for Neonatal Hearing Screening Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Auditory Brainstem Response (ABR) Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Auditory Brainstem Response (ABR) Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 7: World 16-Year Perspective for Auditory Brainstem Response (ABR) Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Otoacoustic Emission (OAE) Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Otoacoustic Emission (OAE) Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 10: World 16-Year Perspective for Otoacoustic Emission (OAE) Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Combination Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Combination Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 13: World 16-Year Perspective for Combination Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 16: World 16-Year Perspective for Hospitals End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Specialty Clinics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Specialty Clinics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 19: World 16-Year Perspective for Specialty Clinics End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 22: World 16-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Neonatal Hearing Screening Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 23: USA Recent Past, Current & Future Analysis for Neonatal Hearing Screening Devices by Product - Auditory Brainstem Response (ABR) Systems, Otoacoustic Emission (OAE) Systems and Combination Systems - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 24: USA Historic Review for Neonatal Hearing Screening Devices by Product - Auditory Brainstem Response (ABR) Systems, Otoacoustic Emission (OAE) Systems and Combination Systems Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 25: USA 16-Year Perspective for Neonatal Hearing Screening Devices by Product - Percentage Breakdown of Value Sales for Auditory Brainstem Response (ABR) Systems, Otoacoustic Emission (OAE) Systems and Combination Systems for the Years 2014, 2024 & 2030
    • TABLE 26: USA Recent Past, Current & Future Analysis for Neonatal Hearing Screening Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 27: USA Historic Review for Neonatal Hearing Screening Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 28: USA 16-Year Perspective for Neonatal Hearing Screening Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 29: Canada Recent Past, Current & Future Analysis for Neonatal Hearing Screening Devices by Product - Auditory Brainstem Response (ABR) Systems, Otoacoustic Emission (OAE) Systems and Combination Systems - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 30: Canada Historic Review for Neonatal Hearing Screening Devices by Product - Auditory Brainstem Response (ABR) Systems, Otoacoustic Emission (OAE) Systems and Combination Systems Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 31: Canada 16-Year Perspective for Neonatal Hearing Screening Devices by Product - Percentage Breakdown of Value Sales for Auditory Brainstem Response (ABR) Systems, Otoacoustic Emission (OAE) Systems and Combination Systems for the Years 2014, 2024 & 2030
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Neonatal Hearing Screening Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 33: Canada Historic Review for Neonatal Hearing Screening Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 34: Canada 16-Year Perspective for Neonatal Hearing Screening Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • JAPAN
    • Neonatal Hearing Screening Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 35: Japan Recent Past, Current & Future Analysis for Neonatal Hearing Screening Devices by Product - Auditory Brainstem Response (ABR) Systems, Otoacoustic Emission (OAE) Systems and Combination Systems - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 36: Japan Historic Review for Neonatal Hearing Screening Devices by Product - Auditory Brainstem Response (ABR) Systems, Otoacoustic Emission (OAE) Systems and Combination Systems Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 37: Japan 16-Year Perspective for Neonatal Hearing Screening Devices by Product - Percentage Breakdown of Value Sales for Auditory Brainstem Response (ABR) Systems, Otoacoustic Emission (OAE) Systems and Combination Systems for the Years 2014, 2024 & 2030
    • TABLE 38: Japan Recent Past, Current & Future Analysis for Neonatal Hearing Screening Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 39: Japan Historic Review for Neonatal Hearing Screening Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 40: Japan 16-Year Perspective for Neonatal Hearing Screening Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • CHINA
    • Neonatal Hearing Screening Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 41: China Recent Past, Current & Future Analysis for Neonatal Hearing Screening Devices by Product - Auditory Brainstem Response (ABR) Systems, Otoacoustic Emission (OAE) Systems and Combination Systems - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 42: China Historic Review for Neonatal Hearing Screening Devices by Product - Auditory Brainstem Response (ABR) Systems, Otoacoustic Emission (OAE) Systems and Combination Systems Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 43: China 16-Year Perspective for Neonatal Hearing Screening Devices by Product - Percentage Breakdown of Value Sales for Auditory Brainstem Response (ABR) Systems, Otoacoustic Emission (OAE) Systems and Combination Systems for the Years 2014, 2024 & 2030
    • TABLE 44: China Recent Past, Current & Future Analysis for Neonatal Hearing Screening Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 45: China Historic Review for Neonatal Hearing Screening Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 46: China 16-Year Perspective for Neonatal Hearing Screening Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • EUROPE
    • Neonatal Hearing Screening Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 47: Europe Recent Past, Current & Future Analysis for Neonatal Hearing Screening Devices by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
    • TABLE 48: Europe Historic Review for Neonatal Hearing Screening Devices by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 49: Europe 16-Year Perspective for Neonatal Hearing Screening Devices by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Neonatal Hearing Screening Devices by Product - Auditory Brainstem Response (ABR) Systems, Otoacoustic Emission (OAE) Systems and Combination Systems - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Neonatal Hearing Screening Devices by Product - Auditory Brainstem Response (ABR) Systems, Otoacoustic Emission (OAE) Systems and Combination Systems Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 52: Europe 16-Year Perspective for Neonatal Hearing Screening Devices by Product - Percentage Breakdown of Value Sales for Auditory Brainstem Response (ABR) Systems, Otoacoustic Emission (OAE) Systems and Combination Systems for the Years 2014, 2024 & 2030
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Neonatal Hearing Screening Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for Neonatal Hearing Screening Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 55: Europe 16-Year Perspective for Neonatal Hearing Screening Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • FRANCE
    • Neonatal Hearing Screening Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 56: France Recent Past, Current & Future Analysis for Neonatal Hearing Screening Devices by Product - Auditory Brainstem Response (ABR) Systems, Otoacoustic Emission (OAE) Systems and Combination Systems - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 57: France Historic Review for Neonatal Hearing Screening Devices by Product - Auditory Brainstem Response (ABR) Systems, Otoacoustic Emission (OAE) Systems and Combination Systems Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 58: France 16-Year Perspective for Neonatal Hearing Screening Devices by Product - Percentage Breakdown of Value Sales for Auditory Brainstem Response (ABR) Systems, Otoacoustic Emission (OAE) Systems and Combination Systems for the Years 2014, 2024 & 2030
    • TABLE 59: France Recent Past, Current & Future Analysis for Neonatal Hearing Screening Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 60: France Historic Review for Neonatal Hearing Screening Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 61: France 16-Year Perspective for Neonatal Hearing Screening Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • GERMANY
    • Neonatal Hearing Screening Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 62: Germany Recent Past, Current & Future Analysis for Neonatal Hearing Screening Devices by Product - Auditory Brainstem Response (ABR) Systems, Otoacoustic Emission (OAE) Systems and Combination Systems - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 63: Germany Historic Review for Neonatal Hearing Screening Devices by Product - Auditory Brainstem Response (ABR) Systems, Otoacoustic Emission (OAE) Systems and Combination Systems Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 64: Germany 16-Year Perspective for Neonatal Hearing Screening Devices by Product - Percentage Breakdown of Value Sales for Auditory Brainstem Response (ABR) Systems, Otoacoustic Emission (OAE) Systems and Combination Systems for the Years 2014, 2024 & 2030
    • TABLE 65: Germany Recent Past, Current & Future Analysis for Neonatal Hearing Screening Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 66: Germany Historic Review for Neonatal Hearing Screening Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 67: Germany 16-Year Perspective for Neonatal Hearing Screening Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 68: Italy Recent Past, Current & Future Analysis for Neonatal Hearing Screening Devices by Product - Auditory Brainstem Response (ABR) Systems, Otoacoustic Emission (OAE) Systems and Combination Systems - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 69: Italy Historic Review for Neonatal Hearing Screening Devices by Product - Auditory Brainstem Response (ABR) Systems, Otoacoustic Emission (OAE) Systems and Combination Systems Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 70: Italy 16-Year Perspective for Neonatal Hearing Screening Devices by Product - Percentage Breakdown of Value Sales for Auditory Brainstem Response (ABR) Systems, Otoacoustic Emission (OAE) Systems and Combination Systems for the Years 2014, 2024 & 2030
    • TABLE 71: Italy Recent Past, Current & Future Analysis for Neonatal Hearing Screening Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 72: Italy Historic Review for Neonatal Hearing Screening Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 73: Italy 16-Year Perspective for Neonatal Hearing Screening Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Neonatal Hearing Screening Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 74: UK Recent Past, Current & Future Analysis for Neonatal Hearing Screening Devices by Product - Auditory Brainstem Response (ABR) Systems, Otoacoustic Emission (OAE) Systems and Combination Systems - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 75: UK Historic Review for Neonatal Hearing Screening Devices by Product - Auditory Brainstem Response (ABR) Systems, Otoacoustic Emission (OAE) Systems and Combination Systems Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 76: UK 16-Year Perspective for Neonatal Hearing Screening Devices by Product - Percentage Breakdown of Value Sales for Auditory Brainstem Response (ABR) Systems, Otoacoustic Emission (OAE) Systems and Combination Systems for the Years 2014, 2024 & 2030
    • TABLE 77: UK Recent Past, Current & Future Analysis for Neonatal Hearing Screening Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 78: UK Historic Review for Neonatal Hearing Screening Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 79: UK 16-Year Perspective for Neonatal Hearing Screening Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • SPAIN
    • TABLE 80: Spain Recent Past, Current & Future Analysis for Neonatal Hearing Screening Devices by Product - Auditory Brainstem Response (ABR) Systems, Otoacoustic Emission (OAE) Systems and Combination Systems - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 81: Spain Historic Review for Neonatal Hearing Screening Devices by Product - Auditory Brainstem Response (ABR) Systems, Otoacoustic Emission (OAE) Systems and Combination Systems Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 82: Spain 16-Year Perspective for Neonatal Hearing Screening Devices by Product - Percentage Breakdown of Value Sales for Auditory Brainstem Response (ABR) Systems, Otoacoustic Emission (OAE) Systems and Combination Systems for the Years 2014, 2024 & 2030
    • TABLE 83: Spain Recent Past, Current & Future Analysis for Neonatal Hearing Screening Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 84: Spain Historic Review for Neonatal Hearing Screening Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 85: Spain 16-Year Perspective for Neonatal Hearing Screening Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • RUSSIA
    • TABLE 86: Russia Recent Past, Current & Future Analysis for Neonatal Hearing Screening Devices by Product - Auditory Brainstem Response (ABR) Systems, Otoacoustic Emission (OAE) Systems and Combination Systems - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Russia Historic Review for Neonatal Hearing Screening Devices by Product - Auditory Brainstem Response (ABR) Systems, Otoacoustic Emission (OAE) Systems and Combination Systems Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 88: Russia 16-Year Perspective for Neonatal Hearing Screening Devices by Product - Percentage Breakdown of Value Sales for Auditory Brainstem Response (ABR) Systems, Otoacoustic Emission (OAE) Systems and Combination Systems for the Years 2014, 2024 & 2030
    • TABLE 89: Russia Recent Past, Current & Future Analysis for Neonatal Hearing Screening Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 90: Russia Historic Review for Neonatal Hearing Screening Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 91: Russia 16-Year Perspective for Neonatal Hearing Screening Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 92: Rest of Europe Recent Past, Current & Future Analysis for Neonatal Hearing Screening Devices by Product - Auditory Brainstem Response (ABR) Systems, Otoacoustic Emission (OAE) Systems and Combination Systems - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Rest of Europe Historic Review for Neonatal Hearing Screening Devices by Product - Auditory Brainstem Response (ABR) Systems, Otoacoustic Emission (OAE) Systems and Combination Systems Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 94: Rest of Europe 16-Year Perspective for Neonatal Hearing Screening Devices by Product - Percentage Breakdown of Value Sales for Auditory Brainstem Response (ABR) Systems, Otoacoustic Emission (OAE) Systems and Combination Systems for the Years 2014, 2024 & 2030
    • TABLE 95: Rest of Europe Recent Past, Current & Future Analysis for Neonatal Hearing Screening Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Rest of Europe Historic Review for Neonatal Hearing Screening Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 97: Rest of Europe 16-Year Perspective for Neonatal Hearing Screening Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Neonatal Hearing Screening Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for Neonatal Hearing Screening Devices by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
    • TABLE 99: Asia-Pacific Historic Review for Neonatal Hearing Screening Devices by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 100: Asia-Pacific 16-Year Perspective for Neonatal Hearing Screening Devices by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
    • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Neonatal Hearing Screening Devices by Product - Auditory Brainstem Response (ABR) Systems, Otoacoustic Emission (OAE) Systems and Combination Systems - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 102: Asia-Pacific Historic Review for Neonatal Hearing Screening Devices by Product - Auditory Brainstem Response (ABR) Systems, Otoacoustic Emission (OAE) Systems and Combination Systems Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 103: Asia-Pacific 16-Year Perspective for Neonatal Hearing Screening Devices by Product - Percentage Breakdown of Value Sales for Auditory Brainstem Response (ABR) Systems, Otoacoustic Emission (OAE) Systems and Combination Systems for the Years 2014, 2024 & 2030
    • TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for Neonatal Hearing Screening Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 105: Asia-Pacific Historic Review for Neonatal Hearing Screening Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 106: Asia-Pacific 16-Year Perspective for Neonatal Hearing Screening Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • AUSTRALIA
    • Neonatal Hearing Screening Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
    • TABLE 107: Australia Recent Past, Current & Future Analysis for Neonatal Hearing Screening Devices by Product - Auditory Brainstem Response (ABR) Systems, Otoacoustic Emission (OAE) Systems and Combination Systems - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 108: Australia Historic Review for Neonatal Hearing Screening Devices by Product - Auditory Brainstem Response (ABR) Systems, Otoacoustic Emission (OAE) Systems and Combination Systems Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 109: Australia 16-Year Perspective for Neonatal Hearing Screening Devices by Product - Percentage Breakdown of Value Sales for Auditory Brainstem Response (ABR) Systems, Otoacoustic Emission (OAE) Systems and Combination Systems for the Years 2014, 2024 & 2030
    • TABLE 110: Australia Recent Past, Current & Future Analysis for Neonatal Hearing Screening Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 111: Australia Historic Review for Neonatal Hearing Screening Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 112: Australia 16-Year Perspective for Neonatal Hearing Screening Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • INDIA
    • Neonatal Hearing Screening Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
    • TABLE 113: India Recent Past, Current & Future Analysis for Neonatal Hearing Screening Devices by Product - Auditory Brainstem Response (ABR) Systems, Otoacoustic Emission (OAE) Systems and Combination Systems - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 114: India Historic Review for Neonatal Hearing Screening Devices by Product - Auditory Brainstem Response (ABR) Systems, Otoacoustic Emission (OAE) Systems and Combination Systems Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 115: India 16-Year Perspective for Neonatal Hearing Screening Devices by Product - Percentage Breakdown of Value Sales for Auditory Brainstem Response (ABR) Systems, Otoacoustic Emission (OAE) Systems and Combination Systems for the Years 2014, 2024 & 2030
    • TABLE 116: India Recent Past, Current & Future Analysis for Neonatal Hearing Screening Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 117: India Historic Review for Neonatal Hearing Screening Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 118: India 16-Year Perspective for Neonatal Hearing Screening Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • SOUTH KOREA
    • TABLE 119: South Korea Recent Past, Current & Future Analysis for Neonatal Hearing Screening Devices by Product - Auditory Brainstem Response (ABR) Systems, Otoacoustic Emission (OAE) Systems and Combination Systems - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 120: South Korea Historic Review for Neonatal Hearing Screening Devices by Product - Auditory Brainstem Response (ABR) Systems, Otoacoustic Emission (OAE) Systems and Combination Systems Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 121: South Korea 16-Year Perspective for Neonatal Hearing Screening Devices by Product - Percentage Breakdown of Value Sales for Auditory Brainstem Response (ABR) Systems, Otoacoustic Emission (OAE) Systems and Combination Systems for the Years 2014, 2024 & 2030
    • TABLE 122: South Korea Recent Past, Current & Future Analysis for Neonatal Hearing Screening Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 123: South Korea Historic Review for Neonatal Hearing Screening Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 124: South Korea 16-Year Perspective for Neonatal Hearing Screening Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 125: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Neonatal Hearing Screening Devices by Product - Auditory Brainstem Response (ABR) Systems, Otoacoustic Emission (OAE) Systems and Combination Systems - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 126: Rest of Asia-Pacific Historic Review for Neonatal Hearing Screening Devices by Product - Auditory Brainstem Response (ABR) Systems, Otoacoustic Emission (OAE) Systems and Combination Systems Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 127: Rest of Asia-Pacific 16-Year Perspective for Neonatal Hearing Screening Devices by Product - Percentage Breakdown of Value Sales for Auditory Brainstem Response (ABR) Systems, Otoacoustic Emission (OAE) Systems and Combination Systems for the Years 2014, 2024 & 2030
    • TABLE 128: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Neonatal Hearing Screening Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 129: Rest of Asia-Pacific Historic Review for Neonatal Hearing Screening Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 130: Rest of Asia-Pacific 16-Year Perspective for Neonatal Hearing Screening Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • LATIN AMERICA
    • Neonatal Hearing Screening Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
    • TABLE 131: Latin America Recent Past, Current & Future Analysis for Neonatal Hearing Screening Devices by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
    • TABLE 132: Latin America Historic Review for Neonatal Hearing Screening Devices by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 133: Latin America 16-Year Perspective for Neonatal Hearing Screening Devices by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
    • TABLE 134: Latin America Recent Past, Current & Future Analysis for Neonatal Hearing Screening Devices by Product - Auditory Brainstem Response (ABR) Systems, Otoacoustic Emission (OAE) Systems and Combination Systems - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 135: Latin America Historic Review for Neonatal Hearing Screening Devices by Product - Auditory Brainstem Response (ABR) Systems, Otoacoustic Emission (OAE) Systems and Combination Systems Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 136: Latin America 16-Year Perspective for Neonatal Hearing Screening Devices by Product - Percentage Breakdown of Value Sales for Auditory Brainstem Response (ABR) Systems, Otoacoustic Emission (OAE) Systems and Combination Systems for the Years 2014, 2024 & 2030
    • TABLE 137: Latin America Recent Past, Current & Future Analysis for Neonatal Hearing Screening Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 138: Latin America Historic Review for Neonatal Hearing Screening Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 139: Latin America 16-Year Perspective for Neonatal Hearing Screening Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • ARGENTINA
    • TABLE 140: Argentina Recent Past, Current & Future Analysis for Neonatal Hearing Screening Devices by Product - Auditory Brainstem Response (ABR) Systems, Otoacoustic Emission (OAE) Systems and Combination Systems - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 141: Argentina Historic Review for Neonatal Hearing Screening Devices by Product - Auditory Brainstem Response (ABR) Systems, Otoacoustic Emission (OAE) Systems and Combination Systems Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 142: Argentina 16-Year Perspective for Neonatal Hearing Screening Devices by Product - Percentage Breakdown of Value Sales for Auditory Brainstem Response (ABR) Systems, Otoacoustic Emission (OAE) Systems and Combination Systems for the Years 2014, 2024 & 2030
    • TABLE 143: Argentina Recent Past, Current & Future Analysis for Neonatal Hearing Screening Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 144: Argentina Historic Review for Neonatal Hearing Screening Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 145: Argentina 16-Year Perspective for Neonatal Hearing Screening Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • BRAZIL
    • TABLE 146: Brazil Recent Past, Current & Future Analysis for Neonatal Hearing Screening Devices by Product - Auditory Brainstem Response (ABR) Systems, Otoacoustic Emission (OAE) Systems and Combination Systems - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 147: Brazil Historic Review for Neonatal Hearing Screening Devices by Product - Auditory Brainstem Response (ABR) Systems, Otoacoustic Emission (OAE) Systems and Combination Systems Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 148: Brazil 16-Year Perspective for Neonatal Hearing Screening Devices by Product - Percentage Breakdown of Value Sales for Auditory Brainstem Response (ABR) Systems, Otoacoustic Emission (OAE) Systems and Combination Systems for the Years 2014, 2024 & 2030
    • TABLE 149: Brazil Recent Past, Current & Future Analysis for Neonatal Hearing Screening Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 150: Brazil Historic Review for Neonatal Hearing Screening Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 151: Brazil 16-Year Perspective for Neonatal Hearing Screening Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • MEXICO
    • TABLE 152: Mexico Recent Past, Current & Future Analysis for Neonatal Hearing Screening Devices by Product - Auditory Brainstem Response (ABR) Systems, Otoacoustic Emission (OAE) Systems and Combination Systems - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 153: Mexico Historic Review for Neonatal Hearing Screening Devices by Product - Auditory Brainstem Response (ABR) Systems, Otoacoustic Emission (OAE) Systems and Combination Systems Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 154: Mexico 16-Year Perspective for Neonatal Hearing Screening Devices by Product - Percentage Breakdown of Value Sales for Auditory Brainstem Response (ABR) Systems, Otoacoustic Emission (OAE) Systems and Combination Systems for the Years 2014, 2024 & 2030
    • TABLE 155: Mexico Recent Past, Current & Future Analysis for Neonatal Hearing Screening Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 156: Mexico Historic Review for Neonatal Hearing Screening Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 157: Mexico 16-Year Perspective for Neonatal Hearing Screening Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • REST OF LATIN AMERICA
    • TABLE 158: Rest of Latin America Recent Past, Current & Future Analysis for Neonatal Hearing Screening Devices by Product - Auditory Brainstem Response (ABR) Systems, Otoacoustic Emission (OAE) Systems and Combination Systems - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 159: Rest of Latin America Historic Review for Neonatal Hearing Screening Devices by Product - Auditory Brainstem Response (ABR) Systems, Otoacoustic Emission (OAE) Systems and Combination Systems Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 160: Rest of Latin America 16-Year Perspective for Neonatal Hearing Screening Devices by Product - Percentage Breakdown of Value Sales for Auditory Brainstem Response (ABR) Systems, Otoacoustic Emission (OAE) Systems and Combination Systems for the Years 2014, 2024 & 2030
    • TABLE 161: Rest of Latin America Recent Past, Current & Future Analysis for Neonatal Hearing Screening Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 162: Rest of Latin America Historic Review for Neonatal Hearing Screening Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 163: Rest of Latin America 16-Year Perspective for Neonatal Hearing Screening Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • MIDDLE EAST
    • Neonatal Hearing Screening Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
    • TABLE 164: Middle East Recent Past, Current & Future Analysis for Neonatal Hearing Screening Devices by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
    • TABLE 165: Middle East Historic Review for Neonatal Hearing Screening Devices by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 166: Middle East 16-Year Perspective for Neonatal Hearing Screening Devices by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
    • TABLE 167: Middle East Recent Past, Current & Future Analysis for Neonatal Hearing Screening Devices by Product - Auditory Brainstem Response (ABR) Systems, Otoacoustic Emission (OAE) Systems and Combination Systems - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 168: Middle East Historic Review for Neonatal Hearing Screening Devices by Product - Auditory Brainstem Response (ABR) Systems, Otoacoustic Emission (OAE) Systems and Combination Systems Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 169: Middle East 16-Year Perspective for Neonatal Hearing Screening Devices by Product - Percentage Breakdown of Value Sales for Auditory Brainstem Response (ABR) Systems, Otoacoustic Emission (OAE) Systems and Combination Systems for the Years 2014, 2024 & 2030
    • TABLE 170: Middle East Recent Past, Current & Future Analysis for Neonatal Hearing Screening Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 171: Middle East Historic Review for Neonatal Hearing Screening Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 172: Middle East 16-Year Perspective for Neonatal Hearing Screening Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • IRAN
    • TABLE 173: Iran Recent Past, Current & Future Analysis for Neonatal Hearing Screening Devices by Product - Auditory Brainstem Response (ABR) Systems, Otoacoustic Emission (OAE) Systems and Combination Systems - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 174: Iran Historic Review for Neonatal Hearing Screening Devices by Product - Auditory Brainstem Response (ABR) Systems, Otoacoustic Emission (OAE) Systems and Combination Systems Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 175: Iran 16-Year Perspective for Neonatal Hearing Screening Devices by Product - Percentage Breakdown of Value Sales for Auditory Brainstem Response (ABR) Systems, Otoacoustic Emission (OAE) Systems and Combination Systems for the Years 2014, 2024 & 2030
    • TABLE 176: Iran Recent Past, Current & Future Analysis for Neonatal Hearing Screening Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 177: Iran Historic Review for Neonatal Hearing Screening Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 178: Iran 16-Year Perspective for Neonatal Hearing Screening Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • ISRAEL
    • TABLE 179: Israel Recent Past, Current & Future Analysis for Neonatal Hearing Screening Devices by Product - Auditory Brainstem Response (ABR) Systems, Otoacoustic Emission (OAE) Systems and Combination Systems - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 180: Israel Historic Review for Neonatal Hearing Screening Devices by Product - Auditory Brainstem Response (ABR) Systems, Otoacoustic Emission (OAE) Systems and Combination Systems Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 181: Israel 16-Year Perspective for Neonatal Hearing Screening Devices by Product - Percentage Breakdown of Value Sales for Auditory Brainstem Response (ABR) Systems, Otoacoustic Emission (OAE) Systems and Combination Systems for the Years 2014, 2024 & 2030
    • TABLE 182: Israel Recent Past, Current & Future Analysis for Neonatal Hearing Screening Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 183: Israel Historic Review for Neonatal Hearing Screening Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 184: Israel 16-Year Perspective for Neonatal Hearing Screening Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • SAUDI ARABIA
    • TABLE 185: Saudi Arabia Recent Past, Current & Future Analysis for Neonatal Hearing Screening Devices by Product - Auditory Brainstem Response (ABR) Systems, Otoacoustic Emission (OAE) Systems and Combination Systems - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 186: Saudi Arabia Historic Review for Neonatal Hearing Screening Devices by Product - Auditory Brainstem Response (ABR) Systems, Otoacoustic Emission (OAE) Systems and Combination Systems Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 187: Saudi Arabia 16-Year Perspective for Neonatal Hearing Screening Devices by Product - Percentage Breakdown of Value Sales for Auditory Brainstem Response (ABR) Systems, Otoacoustic Emission (OAE) Systems and Combination Systems for the Years 2014, 2024 & 2030
    • TABLE 188: Saudi Arabia Recent Past, Current & Future Analysis for Neonatal Hearing Screening Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 189: Saudi Arabia Historic Review for Neonatal Hearing Screening Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 190: Saudi Arabia 16-Year Perspective for Neonatal Hearing Screening Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 191: UAE Recent Past, Current & Future Analysis for Neonatal Hearing Screening Devices by Product - Auditory Brainstem Response (ABR) Systems, Otoacoustic Emission (OAE) Systems and Combination Systems - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 192: UAE Historic Review for Neonatal Hearing Screening Devices by Product - Auditory Brainstem Response (ABR) Systems, Otoacoustic Emission (OAE) Systems and Combination Systems Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 193: UAE 16-Year Perspective for Neonatal Hearing Screening Devices by Product - Percentage Breakdown of Value Sales for Auditory Brainstem Response (ABR) Systems, Otoacoustic Emission (OAE) Systems and Combination Systems for the Years 2014, 2024 & 2030
    • TABLE 194: UAE Recent Past, Current & Future Analysis for Neonatal Hearing Screening Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 195: UAE Historic Review for Neonatal Hearing Screening Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 196: UAE 16-Year Perspective for Neonatal Hearing Screening Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • REST OF MIDDLE EAST
    • TABLE 197: Rest of Middle East Recent Past, Current & Future Analysis for Neonatal Hearing Screening Devices by Product - Auditory Brainstem Response (ABR) Systems, Otoacoustic Emission (OAE) Systems and Combination Systems - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 198: Rest of Middle East Historic Review for Neonatal Hearing Screening Devices by Product - Auditory Brainstem Response (ABR) Systems, Otoacoustic Emission (OAE) Systems and Combination Systems Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 199: Rest of Middle East 16-Year Perspective for Neonatal Hearing Screening Devices by Product - Percentage Breakdown of Value Sales for Auditory Brainstem Response (ABR) Systems, Otoacoustic Emission (OAE) Systems and Combination Systems for the Years 2014, 2024 & 2030
    • TABLE 200: Rest of Middle East Recent Past, Current & Future Analysis for Neonatal Hearing Screening Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 201: Rest of Middle East Historic Review for Neonatal Hearing Screening Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 202: Rest of Middle East 16-Year Perspective for Neonatal Hearing Screening Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • AFRICA
    • Neonatal Hearing Screening Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
    • TABLE 203: Africa Recent Past, Current & Future Analysis for Neonatal Hearing Screening Devices by Product - Auditory Brainstem Response (ABR) Systems, Otoacoustic Emission (OAE) Systems and Combination Systems - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 204: Africa Historic Review for Neonatal Hearing Screening Devices by Product - Auditory Brainstem Response (ABR) Systems, Otoacoustic Emission (OAE) Systems and Combination Systems Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 205: Africa 16-Year Perspective for Neonatal Hearing Screening Devices by Product - Percentage Breakdown of Value Sales for Auditory Brainstem Response (ABR) Systems, Otoacoustic Emission (OAE) Systems and Combination Systems for the Years 2014, 2024 & 2030
    • TABLE 206: Africa Recent Past, Current & Future Analysis for Neonatal Hearing Screening Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 207: Africa Historic Review for Neonatal Hearing Screening Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 208: Africa 16-Year Perspective for Neonatal Hearing Screening Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses for the Years 2014, 2024 & 2030

IV. COMPETITION